← FDA DRUG APPROVALS

FDA ANDA · ANDA072409

NIFEDIPINE

Sponsor: CHASE LABS NJ

APPLICATION
ANDA072409
TYPE
ANDA
ORIGINAL APPROVAL
1989-07-10
LATEST ACTION
1992-08-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

NIFEDIPINEDiscontinued
NIFEDIPINE 10MG · CAPSULE · ORAL

Approval history

1992-08-06Labeling · Supplement 10AP
1992-04-16Labeling · Supplement 7AP
1991-09-12Labeling · Supplement 5AP
1989-07-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →